TROW

Over the past six months (April 2026 - October 2026), T. Rowe Price Group, Inc. (TROW) stock decreased by 5.65% in the past month as of October 3, 2026, while increasing by 1.30% over the last 12 months with a year-to-date return of 2.19%. Key events include Evercore ISI Group maintaining an 'In-Line' rating but lowering the price target to $109.00 in October 2026, and UBS Group initiating coverage with a 'neutral' rating and a $107.00 price objective. In October, T. Rowe Price also announced a new Dynamic Emerging Markets Bond ETF. In September 2026, the company reported aggregate assets under management rose despite $7.9 billion in August outflows and debuted Biotech, Small-Cap, and Mid-Cap Exchange Traded Funds, while Evercore increased its target price to $121.00. August 2026 saw BMO Capital Markets raising its target price to $120.00 and maintaining a 'market perform' rating, and Deutsche Bank Aktiengesellschaft restating a 'hold' rating with a $109.00 price objective. In July 2026, T. Rowe Price reported Q2 2026 earnings with earnings per share of $2.57, beating estimates, and revenue up 8.3% year-on-year. In June 2026, The Goldman Sachs Group boosted its price target to $92.00 but maintained a 'sell' rating. The company has experienced continued net outflows in client assets, totaling $6.5 billion in fiscal Q2 2026, $8.2 billion in July 2026, and $7.9 billion in August 2026, particularly from higher-fee active equity strategies, alongside pressure on fee rates and a shift towards lower-cost products.